HCA Healthcare Inc (NYSE:HCA) opened Thursday sharply lower on its latest figures.
The company has posted Q4 revenues of $15.1 billion, compared to $14.29 billion a year ago and missing the consensus of $15.37 billion.
EPS were $4.42, higher than $4.13 reported in 4Q of 2020, but missed the estimate of $4.54.
CEO Sam Hazen says, "The omicron surge started to influence our business in early December."
Same facility admissions increased 0.6% Y/Y, and same facility equivalent admissions increased 4.1%.
Same facility revenue per equivalent admission increased 2.2%.
Adjusted EBITDA totaled $3.15 billion, compared to $3.12 billion in Q4 FY20.
HCA Healthcare declared a quarterly cash dividend of $0.56 per share, payable on March 31, at the record date of March 17. As well, the company expects revenues of $60 billion - $62 billion, compared to the consensus of $61.48 billion.
It expects an adjusted EBITDA of $12.55 billion - $13.05 billion. HCA sees diluted EPS of $18.40 - $19.20 versus the consensus of $18.73.
Same facility admissions and same facility equivalent admissions increased 0.6%, and 4.1% respectively, in the fourth quarter of 2021 compared to the prior year period.
Same facility emergency room visits increased 19.6% in the fourth quarter of 2021, compared to the prior year period. Same facility inpatient surgeries declined 1.2% and same facility outpatient surgeries increased 5.2% in the fourth quarter of 2021, compared to the same period of 2020. Same facility revenue per equivalent admission increased 2.2% in the fourth quarter of 2021, compared to the fourth quarter of 2020.
HCA shares were down $14.96, or 6.2% at $224.92 Thursday.
Related Stories
